Pharmacodynamic Dose-Response and Safety Study of Cisatracurium (51W89) in Adult Surgical Patients During N2 O-O2-Opioid Anesthesia
Authors:
- Jean-Yves LepageJLJean-Yves Lepage
- Jean-Marc MalinovskyJMJean-Marc Malinovsky
- Myriam MalingeMMMyriam Malinge
- Thierry LechevalierTLThierry Lechevalier
- Christine DupuchCDChristine Dupuch
- Antoine CozianACAntoine Cozian
- Michel PinaudMPMichel Pinaud
- Remy SouronRSRemy Souron
- 1 October 1996
- journal article
- Published by Wolters Kluwer Health in Anesthesia & Analgesia
- Vol. 83 (4) , 823-829
Abstract
No abstract availableThis publication has 26 references indexed in Scilit:
- The Clinical Neuromuscular Pharmacology of 51W89 in Patients Receiving Nitrous Oxide/Opioid/Barbiturate AnesthesiaAnesthesiology, 1995
- Evaluation of 51W89 for Tracheal Intubation in Surgical Patients during Nitrous Oxide/Oxygen/Propofol AnesthesiaAnesthesiology, 1994
- Pharmacodynamics and Histamine Releasing Potency of High-dose 51W89 J. Y. LepageAnesthesiology, 1994
- The Neuromuscular Effects of ORG9426 in Patients Receiving Balanced AnesthesiaAnesthesiology, 1991
- Neuromuscular and cardiovascular effects of pipecuroniumCanadian Journal of Anesthesia/Journal canadien d'anesthésie, 1990
- Pancuronium, Gallamine, and d-Tubocurarine ComparedAnesthesiology, 1989
- The Clinical Neuromuscular Pharmacology of Mivacurium Chloride (BW B1090U). A Short-acting Nondepolarizing Ester Neuromuscular Blocking DrugAnesthesiology, 1988
- A new radioenzymatic assay for histamine using purified histamine N-methyltransferaseLife Sciences, 1983
- Clinical Pharmacology of Atracurium Besylate (BW 33A)Anesthesia & Analgesia, 1982
- Clinical Pharmacology of ORG NC45 (NorcuronTM)Anesthesiology, 1981